(Q24236602)

5

object named as

I Brent Masters

0 references

author name string

Danielle Wurzel

1

0 references

Julie M Marchant

2

0 references

Stephanie T Yerkovich

3

0 references

John W Upham

Cochrane Database of Systematic Reviews

4

0 references

publication date

15 June 2011

0 references

published in

0 references

cites work

Effect of antibiotics on purulent sputum in chronic bronchitis and bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Antibiotics and purulent sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Oxygen metabolites stimulate release of high-molecular-weight glycoconjugates by cell and organ cultures of rodent respiratory epithelium via an arachidonic acid-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Anti-inflammatory, membrane-stabilizing interactions of salmeterol with human neutrophils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Bronchiectasis in children: orphan disease or persistent problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Post-infectious bronchiolitis obliterans: clinical, radiological and pulmonary function sequelae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Exacerbations in cystic fibrosis: 4--Non-cystic fibrosis bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

The need to redefine non-cystic fibrosis bronchiectasis in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Prolonged antibiotics for purulent bronchiectasis in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Exhaled breath condensate MMP-9 levels in children with bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Paradigm shift in surgical approaches to spontaneous pneumothorax: VATS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Non-CF bronchiectasis: does knowing the aetiology lead to changes in management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Pharmacotherapy for bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

British Thoracic Society guideline for non-CF bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Aetiology in adult patients with bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

Bronchiectasis in Alaska Native children: causes and clinical courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

Sequential intravenous/oral therapy with ciprofloxacin in severe infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

Amoxycillin in the treatment of chronic non-tuberculous bronchial infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

Ofloxacin compared with amoxycillin in treating infective exacerbations in bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

[Double-blind study of the sulfamethoxazole-trimethoprim association in the treatment of pulmonary infections]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

Role of CFTR mutations in adult bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

Neutrophil-mediated degradation of lung proteoglycans: stimulation by tumor necrosis factor-alpha in sputum of patients with bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

History and evolution of aerosolized therapeutics: overview and introduction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008695.PUB2

7 January 2021

10.1002/14651858.CD008695.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_rkatlk5ez5fffmtd43zxxryccu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rkatlk5ez5fffmtd43zxxryccu

24 November 2022